Samil Pharmaceutical "No Supply Issues for Cold Medicine 'Eorinibuprofen Syrup'... Full Effort to Secure Inventory"
[Asia Economy Reporter Lee Gwan-joo] As the supply of cold medicine faces an emergency amid the resurgence of COVID-19, Samil Pharmaceutical, which supplies the representative children's fever reducer 'Burofen,' announced on the 1st that it is working hard to secure inventory.
Samil Pharmaceutical stated on the same day, "We are making efforts to secure inventory of Children's Burofen Syrup in preparation for a situation similar to the children's fever reducer shortage crisis that occurred last March."
Children's Burofen Syrup has been a steady seller product for 35 years since its launch in 1987. It has antipyretic, analgesic, and anti-inflammatory effects, making it effective for fever, headache, and body aches caused by colds.
Hot Picks Today
"Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- $800 Million Oil Trades Just Before Trump Announcement... U.S. Authorities Launch Investigation
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
- "Am I Really in the Top 30%?" and "Worried About My Girlfriend in the Bottom 70%"... Buzz Over High Oil Price Relief Fund
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
A Samil Pharmaceutical official explained, "We are striving to secure inventory exceeding the average monthly sales volume to prepare for the increase in confirmed cases," adding, "Even during the company-wide vacation period, some personnel on the Children's Burofen Syrup production line are working to make every effort to secure inventory."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
